Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors.

DiCostanzo D, Rosen PP, Gareen I, Franklin S, Lesser M.

Am J Surg Pathol. 1990 Jan;14(1):12-23.

PMID:
2153007
2.

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.

Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A.

Cancer. 2001 May 15;91(10):1862-9.

PMID:
11346867
3.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
4.

An analysis of prognostic features in infiltrating lobular carcinoma of the breast.

Frost AR, Terahata S, Yeh IT, Siegel RS, Overmoyer B, Silverberg SG.

Mod Pathol. 1995 Oct;8(8):830-6.

PMID:
8552571
5.

Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.

Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL.

Cancer. 1998 Dec 15;83(12):2502-8. Review.

PMID:
9874455
6.

Pathologic correlates of prognosis in lymph node-positive breast carcinomas.

Clayton F, Hopkins CL.

Cancer. 1993 Mar 1;71(5):1780-90.

7.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
8.

[Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience].

Casolo P, Raspadori A, Drei B, Amuso D, Mosca D, Amorotti C, Di Blasio P, De Maria R, De Luca G, Colli G, Ganz E.

Ann Ital Chir. 1997 Jan-Feb;68(1):43-7; discussion 48. Italian.

PMID:
9235863
9.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
10.
11.
12.

Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, Stitt L, Radwan JS.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9.

PMID:
9231679
13.
14.
15.

Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.

Mignano JE, Zahurak ML, Chakravarthy A, Piantadosi S, Dooley WC, Gage I.

Cancer. 1999 Oct 1;86(7):1258-62.

PMID:
10506712
16.

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.

White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.

J Am Coll Surg. 1996 Dec;183(6):575-82.

PMID:
8957459
17.

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R.

Cancer. 2006 Aug 15;107(4):696-704.

18.

Factors influencing survival in infiltrating lobular carcinoma of the breast.

Sariego J, Byrd M, Kerstein M, Matsumoto T.

Am Surg. 1993 Jul;59(7):405-9.

PMID:
8391768
20.

Survival in bilateral breast cancer.

Fracchia AA, Robinson D, Legaspi A, Greenall MJ, Kinne DW, Groshen S.

Cancer. 1985 Mar 15;55(6):1414-21.

Items per page

Supplemental Content

Support Center